Delhi: 24 adverse reactions reported on Day 4, two require hospitalisation | Latest News Delhi - Hindustan Times
close_game
close_game

Delhi: 24 adverse reactions reported on Day 4, two require hospitalisation

Jan 22, 2021 01:56 AM IST

On Thursday, Delhi had witnessed its highest number of vaccinations ever since the drive started on January 16 with 73.36% or 5,942 health care workers getting inoculated.

On the fourth day of the Covid-19 vaccination drive, 24 people — or 0.40% of the total number of people receiving the jabs —showed adverse events.

At least 22 of the 24 adverse reactions reported were minor, whereas two people needed hospitalisation. Both the people to be hospitalised had received Covaxin shots, as per data seen by HT.(HT Photo)
At least 22 of the 24 adverse reactions reported were minor, whereas two people needed hospitalisation. Both the people to be hospitalised had received Covaxin shots, as per data seen by HT.(HT Photo)

On Thursday, Delhi had witnessed its highest number of vaccinations ever since the drive started on January 16 with 73.36% or 5,942 health care workers getting inoculated.

Unlock exclusive access to the story of India's general elections, only on the HT App. Download Now!

At least 22 of the 24 adverse reactions reported were minor, whereas two people needed hospitalisation. Both the people to be hospitalised had received Covaxin shots, as per data seen by HT.

However, senior district officials claimed that both the hospitalisations had happened on Wednesday – when Delhi did not have an immunisation drive – following vaccinations that were done on Tuesday.

“There were two people who were admitted for observation on Wednesday and were discharged soon after. Both the people had minor symptoms, such as fever for which they had been admitted. No serious adverse event has been reported in the district,” said a senior official from south-west district that showed the two hospitalisations.

So far, there has been only one severe adverse event following vaccination using Bharat Biotech’s Covaxin. A 22-year-old security guard at the All India Institute of Medial Sciences had developed serious allergic reaction and had to be admitted after getting the shot on January 16.

There have been cases of abnormal heart rate, severe allergic reaction called anaphylaxis, and faintings reported after Serum Institute of India’s Covishield being administered as well. The vaccine is received by people at 75 centres across the city in comparison to six centre that give Covaxin, under the trial mode.

Sixteen cases of AEFI (adverse event following immunisation) were recorded on Tuesday, 26 on Monday and 52 on Saturday.

Unveiling 'Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Saturday, April 13, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On